MYDA Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

MYDA Advisors’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-28,000	Closed	-$4.25M	–	159
2019 Q2	$4.83M	Sell	28,000 -46,500	-62%	-$8.04M	1.64%	14
2019 Q1	$12.6M	Buy	+74,500	New	+$11.1M	6.33%	1
2018 Q4	–	Sell	-1,600	Closed	-$210K	–	150
2018 Q3	$276K	Sell	1,600 -400	-20%	-$57.7K	0.15%	108
2018 Q2	$279K	Buy	+2,000	New	+$284K	0.12%	113
2018 Q1	–	Sell	-13,000	Closed	-$1.72M	–	206
2017 Q4	$1.72M	Buy	+13,000	New	+$1.53M	0.76%	34

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MGIM

M&G Investment Management London, United Kingdom $28.2B AUM 25.87% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

MYDA Advisors's GWPH Position: Q3 2019 in Review

MYDA Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q3 2019, closing a stake of 28,000 shares — an estimated $4.25M sold.

MYDA Advisors first reported a position in GWPH in Q4 2017 and held it in 5 quarters. The position peaked at $12.6M in Q1 2019. 316 funds tracked by Wall St. Rank hold GWPH as of Q3 2019.

MYDA Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q3 2019 after selling out during the quarter.
MYDA Advisors sold 28,000 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2019, an estimated $4.25M.
MYDA Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2017 and held it in 5 quarters.
MYDA Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $12.6M in Q1 2019.
316 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2019.

Based on MYDA Advisors's 13F filing for Q3 2019, filed 13 Nov 2019.